4.4 Review

Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery

期刊

CURRENT CANCER DRUG TARGETS
卷 19, 期 4, 页码 257-276

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1568009618666180628160211

关键词

Nanotechnology; nanomedicine; cancer characteristics; cancer therapy; nanomedicine; tumor angiogenesis

类别

资金

  1. Ministry of Science and Technology of China [2015CB931804]
  2. National Natural Science Foundation of China [81571802, 81871481, 81402781]
  3. Natural Science Foundation of Fujian Province [2016J06020]
  4. Fujian Provincial Youth Top-notch Talent Support Program

向作者/读者索取更多资源

Background: Effective cancer therapy is still a great challenge for modem medical research due to the complex underlying mechanisms of tumorigenesis and tumor metastasis, and the limitations commonly associated with currently used cancer therapeutic options. Nanotechnology has been implemented in cancer therapeutics with immense potential for improving cancer treatment. Objective: Through information about the recent advances regarding cancer hallmarks, we could comprehensively understand the pharmacological effects and explore the mechanisms of the interaction between the \nanomaterials, which could provide opportunities to develop mechanism-based nanomedicine to treat human cancers. Methods: We collected related information and data from articles. Results: In this review, we discussed the characteristics of cancer including tumor angiogenesis, abnormalities in tumor blood vessels, uncontrolled cell proliferation markers, multidrug resistance, tumor metastasis, cancer cell metabolism, and tumor immune system that provide opportunities and challenges for nanomedicine to be directed to specific cancer cells and portray the progress that has been accomplished in application of nanotechnology for cancer treatment. Conclusion: The information presented in this review can provide useful references for further studies on developing effective nanomedicine for the treatment of cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

The Evaluation of Animal Models in the Development of Anticancer Agents: From Preclinical to Clinical Tests

Jie Wang, Haiyan Dong, Jian Liu, Ning Zheng, Xiaodong Xie, Lee Jia

CURRENT CANCER DRUG TARGETS (2019)

Article Oncology

Circulation patterns and seed-soil compatibility factors cooperate to cause cancer organ-specific metastasis

Yusheng Lu, Shu Lian, Yunlong Cheng, Yuying Ye, Xiaodong Xie, Chengbin Fu, Chen Zhang, Yewei Zhu, M. Iqbal Parker, Lee Jia

EXPERIMENTAL CELL RESEARCH (2019)

Correction Multidisciplinary Sciences

Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles (vol 10, 5476, 2019)

Xiaodong Xie, Huifang Nie, Yu Zhou, Shu Lian, Hao Mei, Yusheng Lu, Haiyan Dong, Fengqiao Li, Tao Li, Bifei Li, Jie Wang, Min Lin, Chaihung Wang, Jingwei Shao, Yu Gao, Jianming Chen, Fangwei Xie, Lee Jia

NATURE COMMUNICATIONS (2020)

Article Chemistry, Multidisciplinary

Nanoparticle depots for controlled and sustained gene delivery

Zhongyu Li, William Ho, Xin Bai, Fengqiao Li, Yen-jui Chen, Xue-Qing Zhang, Xiaoyang Xu

JOURNAL OF CONTROLLED RELEASE (2020)

Article Multidisciplinary Sciences

Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment

Ying Ji, Xiangsheng Liu, Juan Li, Xiaodong Xie, Max Huang, Jinhong Jiang, Yu-Pei Liao, Timothy Donahue, Huan Meng

NATURE COMMUNICATIONS (2020)

Article Chemistry, Multidisciplinary

Tumor-derived exosomes can specifically prevent cancer metastatic organotropism

Xiaodong Xie, Shu Lian, Yu Zhou, Bifei Li, Yusheng Lu, Iwin Yeung, Lee Jia

Summary: This study demonstrates that drug-loaded extracellular vesicles derived from breast cancer plasma can inhibit breast cancer metastasis to the lungs, while the CD47 protein helps extend their circulation time in blood, and their tissue distribution ratio mirrors that of companion extracellular vesicles.

JOURNAL OF CONTROLLED RELEASE (2021)

Review Engineering, Biomedical

Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery

William Ho, Mingzhu Gao, Fengqiao Li, Zhongyu Li, Xue-Qing Zhang, Xiaoyang Xu

Summary: Nucleic acid vaccines hold promise as an immunization method for combating pandemics, with nanoparticles being a top candidate for successful DNA/mRNA vaccine delivery due to their unique properties.

ADVANCED HEALTHCARE MATERIALS (2021)

Review Chemistry, Multidisciplinary

Use of Nanoformulation to Target Macrophages for Disease Treatment

Xiangsheng Liu, Xiaodong Xie, Jinhong Jiang, Matthew Lin, Emily Zheng, Waveley Qiu, Iwin Yeung, Motao Zhu, Qinglin Li, Tian Xia, Huan Meng

Summary: Macrophages are vital immune cells that can interact with engineered nanomaterials. Utilizing nanoparticles to target macrophages shows potential in various disease treatments. Understanding the impact of therapeutic NMs on macrophages is crucial for developing effective treatment strategies.

ADVANCED FUNCTIONAL MATERIALS (2021)

Article Chemistry, Multidisciplinary

Interleukin-10 plasmid delivery by polymeric nanocarrier shows efficient and safe tissue repair in acute muscle damage models in mice

Xiaodong Xie, Jinhong Jiang, Xiangsheng Liu, Yuhong Cao, Jiulong Li, Tian Xia, Huan Meng

Summary: We developed a custom-designed nanocarrier for delivering an immunomodulatory plasmid in mice to facilitate tissue repair in acute muscle damage. Through high throughput screening, we identified the best-performing formulation and demonstrated successful delivery of the plasmid to the injured muscle, resulting in accelerated tissue repair. This study highlights the potential of nanocarriers in treating muscle injuries.

NANO TODAY (2022)

Article Pharmacology & Pharmacy

Fucoxanthin prevents breast cancer metastasis by interrupting circulating tumor cells adhesion and transendothelial migration

Weiyu Wang, Chengbin Fu, Mengting Lin, Yusheng Lu, Shu Lian, Xiaodong Xie, Guiyu Zhou, Wulin Li, Yiping Zhang, Lee Jia, Chunlian Zhong, Mingqing Huang

Summary: This study found that fucoxanthin (Fx) can interrupt the adhesion and migration of breast cancer cells, thereby inhibiting the formation of lung metastasis, and it works by affecting cell adhesion molecules and signaling pathways.

FRONTIERS IN PHARMACOLOGY (2022)

Review Biochemistry & Molecular Biology

Cancer metastasis chemoprevention prevents circulating tumour cells from germination

Xiaodong Xie, Yumei Li, Shu Lian, Yusheng Lu, Lee Jia

Summary: This article presents a new cancer pre-metastasis chemoprevention strategy that can potentially prevent lethal metastasis by interrupting the adhesion of circulating tumor cells (CTCs) to their metastasis niche.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Oncology

Tumor-derived Exosome Promotes Metastasis via Altering its Phenotype and Inclusions

Yu Zhou, Fan Chen, Xiaodong Xie, Huifang Nie, Shu Lian, Chunlian Zhong, Chengbin Fu, Weiyu Shen, Bifei Li, Yongqing Ye, Yusheng Lu, Lee Jia

Summary: The study revealed significant differences in inclusions and functions between early and late exosomes of the same tumor, with late tumor exosomes showing a greater ability to promote cell migration. These findings emphasize the importance of exosomes in cancer metastasis and suggest their potential as biomarkers and therapeutic targets for cancer metastasis.

JOURNAL OF CANCER (2021)

Article Chemistry, Multidisciplinary

Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer

Huifang Nie, Xiaodong Xie, Doudou Zhang, Yu Zhou, Bifei Li, Fengqiao Li, Feiyang Li, Yunlong Cheng, Hao Mei, Huan Meng, Lee Jia

NANOSCALE (2020)

暂无数据